These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25332569)
1. A Case of Advanced Primary Thyroid Double-Hit B Cell Lymphoma in Which Complete Remission has been Maintained After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Performed During the Second Remission, with a Review of the Literature. Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):166-73. PubMed ID: 25332569 [TBL] [Abstract][Full Text] [Related]
2. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386 [TBL] [Abstract][Full Text] [Related]
3. [Follicular lymphoma: first - line selection criteria of treatment]. Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757 [TBL] [Abstract][Full Text] [Related]
4. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Bischin AM; Dorer R; Aboulafia DM Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851 [TBL] [Abstract][Full Text] [Related]
5. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328 [TBL] [Abstract][Full Text] [Related]
6. CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma. Intragumtornchai T; Prayoonwiwat W; Numbenjapon T; Assawametha N; O'Charoen R; Swasdikul D Clin Lymphoma; 2000 Dec; 1(3):219-25. PubMed ID: 11707834 [TBL] [Abstract][Full Text] [Related]
7. MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified. Yan LX; Liu YH; Luo DL; Zhang F; Cheng Y; Luo XL; Xu J; Cheng J; Zhuang HG PLoS One; 2014; 9(8):e104068. PubMed ID: 25090026 [TBL] [Abstract][Full Text] [Related]
8. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations]. Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242 [TBL] [Abstract][Full Text] [Related]
9. Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma. Intragumtornchai T; Bunworasate U; Nakorn TN; Rojnuckarin P Leuk Lymphoma; 2006 Jul; 47(7):1306-14. PubMed ID: 16923561 [TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
11. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL. Dunleavy K Curr Treat Options Oncol; 2015 Dec; 16(12):58. PubMed ID: 26634708 [TBL] [Abstract][Full Text] [Related]
17. [Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia]. Huang YQ; Zheng RJ; Wu RJ; Ma XD Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):722-6. PubMed ID: 27342498 [TBL] [Abstract][Full Text] [Related]
19. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. Shi Y; Zhou P; Han X; He X; Zhou S; Liu P; Yang J; Zhang C; Gui L; Qin Y; Yang S; Zhao L; Yao J; Zhang S Chin J Cancer; 2015 Sep; 34(11):522-30. PubMed ID: 26370464 [TBL] [Abstract][Full Text] [Related]
20. [Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon]. Kodama Y; Saburi M; Maruyama R; Sakata M; Takata H; Miyazaki Y; Kawano K; Wada J; Urabe S; Hazuku T; Ohtsuka E Rinsho Ketsueki; 2022; 63(10):1409-1414. PubMed ID: 36351648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]